Bosnia and Herzegovina vs Zambia: Protecting minority investors: Extent of shareholder rights index
Bosnia and Herzegovina
66.67
in 2019
Zambia
66.67
in 2019
Bosnia and Herzegovina rank
65th
Zambia rank
65th
Protecting minority investors: Extent of shareholder rights index over time
- Bosnia and Herzegovina
- Zambia
How they compare
Bosnia and Herzegovina currently reports 66.67 against 66.67 in Zambia, a difference of 0.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 65th and Zambia ranks 65th of 191 countries.
Bosnia and Herzegovina has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: extent of shareholder rights index, Bosnia and Herzegovina or Zambia?
- Bosnia and Herzegovina, at 66.67 against 66.67 in Zambia as of 2019.
- What is the difference in protecting minority investors: extent of shareholder rights index between Bosnia and Herzegovina and Zambia?
- 0, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Zambia?
- 7 years are reported by both, from 2013 to 2019.
- How do Bosnia and Herzegovina and Zambia rank globally for protecting minority investors: extent of shareholder rights index?
- Bosnia and Herzegovina ranks 65th and Zambia ranks 65th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Extent of shareholder rights index (0-6) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for extent of shareholder rights index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.